Technical Analysis for ALGS - Aligos Therapeutics, Inc.

Grade Last Price % Change Price Change
F 21.34 -0.61% -0.13
ALGS closed down 0.61 percent on Monday, April 12, 2021, on 70 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Flat
Historical ALGS trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion 0.00%
Multiple of Ten Bullish Other -0.61%
Wide Bands Range Expansion -0.61%
Multiple of Ten Bullish Other 5.12%
Wide Bands Range Expansion 5.12%
20 DMA Resistance Bearish 3.64%
Wide Bands Range Expansion 3.64%
20 DMA Resistance Bearish -5.83%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.83%
Narrow Range Bar Range Contraction -5.83%
Older End-of-Day Signals for ALGS ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Rose Above Previous Day's High about 4 hours ago
Up 2% about 4 hours ago
10 DMA Support about 6 hours ago
Down 3% about 7 hours ago
Down 2 % about 8 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Aligos Therapeutics, Inc. is a clinical stage biopharmaceutical company that was founded in 2018 with the mission to become a world leader in the treatment of viral infections and liver diseases. Aligos is focused on the development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). Aligos’ strategy is to harness the deep expertise and decades of drug development experience its workforce has in liver disease, particularly viral hepatitis, to rapidly advance its pipeline of potentially best-in-class molecules.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Clinical Medicine Alcohol Drug Development Coronavirus Hepatitis B Viruses Steatohepatitis Hepatitis Liver Disease Non Alcoholic Fatty Liver Disease Infectious Causes Of Cancer Liver Diseases Healthcare Associated Infections Viral Diseases Viral Infection Viral Infections Chronic Hepatitis Antiviral Therapies Chronic Hepatitis B

Is ALGS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.465
52 Week Low 12.82
Average Volume 64,497
200-Day Moving Average 0.00
50-Day Moving Average 24.36
20-Day Moving Average 22.11
10-Day Moving Average 21.38
Average True Range 2.30
ADX 13.69
+DI 14.74
-DI 21.65
Chandelier Exit (Long, 3 ATRs ) 19.64
Chandelier Exit (Short, 3 ATRs ) 24.70
Upper Bollinger Band 26.34
Lower Bollinger Band 17.87
Percent B (%b) 0.41
BandWidth 38.34
MACD Line -1.01
MACD Signal Line -1.15
MACD Histogram 0.1431
Fundamentals Value
Market Cap 747.45 Million
Num Shares 35 Million
EPS
Price-to-Sales 0.00
Price-to-Book 5.43
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 23.49
Resistance 3 (R3) 23.50 22.80 23.13
Resistance 2 (R2) 22.80 22.25 22.79 23.01
Resistance 1 (R1) 22.07 21.92 21.72 22.06 22.89
Pivot Point 21.37 21.37 21.20 21.36 21.37
Support 1 (S1) 20.64 20.82 20.29 20.63 19.79
Support 2 (S2) 19.94 20.49 19.93 19.67
Support 3 (S3) 19.21 19.94 19.55
Support 4 (S4) 19.20